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Endogenous retroviruses in the human DNA probably
result from an exogenous infection of germ line cells. ERV-
W family has been determined to have entered the mam-
malian genome after the speciation of old world mon-
keys, with initial insertion in Catarrhines about 25
million years ago (Voisset et al., 1999). ERV-W copies are
present in old world monkeys, superior primates and in
humans (then named HERV-W).
HERV-W encodes and may express an envelope protein
(ENV), which activates a pro-inflammatory and autoim-
mune cascade through interaction with Toll-Like receptor
4 (TLR4) on antigen-presenting cells. The specific associa-
tion of HERV-W RNA with circulating virion particles
(previously named ''Multiple Sclerosis associated Retrovi-
ral element'', MSRV) with Multiple Sclerosis disease, its
evolution and prognosis has been repeatedly reported.
The role of certain viral infections as triggers for HERV-W
expression has also been characterised. This ENV protein
was evidenced by several independent RT-PCR and immu-
nohistological studies in MS brain lesions post-mortem
(reviewed in Perron et al. Journal of Neurological Sci-
ences, online May 17, 2009).
Using a specific ELISA for HERV-W ENV protein, we report
a significant clustering of ENV antigenaemia in about
75% of MS sera ex-vivo. Large cohorts of blood donors
revealed positive antigenaemia in few healthy individuals
only (p < 0,001).
Moreover, HERV-W ENV protein is shown to reproduce
the ''Experimental Encephalomyelitis'' MS animal model
(EAE) with important inflammatory demyelination evi-
denced by MRI and histology, as well as anti-myelin
autoimmunity. In this MS model, selected anti-ENV mon-
oclonal antibody (mAb) significantly inhibited clinical
symptoms compared to untreated controls. Untreated
''ENV EAE'' mice all died while treated animal survived.
These results now pave the way to the first clinical assess-
ment of a therapeutic agent targeting a human endog-
enous retroviral protein in a human disease. This anti-
ENV mAb has now been humanised and is subjected to
pre-clinical studies.
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